DuPont de Nemours, Inc. · NYSE:DD

DuPont de Nemours — DuPont — Technical Presentation (October 2017)

57 slides from DuPont de Nemours's technical presentation, Oct 5, 2017

  1. Slide 1: Speed Up Your Compliance Process with DuPont Tyvek

    Speed Up Your Compliance Process — With Help from DuPont™ Tyvek® October 5, 2017

  2. Slide 2: DuPont Presenters

    DuPont Presenters Thierry Wagner Nicole Kaller Regulatory Affairs Director— Application & Package Europe, Middle East & Africa Engineering Specialist— Europe, Middle East & Africa Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™, For Greater Good™, Tyvek® and Tyvek® 2FS™

  3. Slide 3: Topics of Today's Discussion

    Topics of Today’s Discussion • Regulatory Update - Global Regulatory Changes - Impact of the New EU MDR/IVDR on Sterile Packaging - Revision Process ISO 11607 • Tools to Help You with Packaging Design and Regulatory Submissions • All New Technical Reference Guide • We’re Here to Help Copyright © 201

  4. Slide 4: Regulatory Update

    Tyvek. Regulatory Update

  5. Slide 5: Disclaimer

    Disclaimer This information corresponds to our current knowledge on the subject and may be subject to revision as new knowledge becomes available. It is your responsibility to investigate other sources of information on this issue that more appropriately addresses your product and its intended use.

  6. Slide 6: Global Regulatory Changes

    Global Regulatory Changes • European Union Adopted its MDR/IVDR in April 2017 to replace the MDD/IVDD • Association of Southeast Asian Nations (ASEAN) Medical Device Directive 2015 • India “Medical Device Rules, 2017” notified in January 2017 • Eurasian Economic Union (EAEU) 2016 Legal framework for

  7. Slide 7: Revision of EN ISO 13485:2016

    Revision of EN ISO 13485:2016 Introduction of state-of-the-art QMS approaches • Scope now includes the life cycle of the device: - Design, resource management and product realization - Storage and distribution, including disposal - Technical support - Complaint handling - Post-market surveillance •

  8. Slide 8: EU Medical Device Regulations

    EU Medical Device Regulations MDD Certificates can be valid up to 4 more years after date of application IVDD Certificates can be valid up to 2 more years after date of application Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™, For Greater Good™, Tyvek® and Tyvek® 2FS™

  9. Slide 9: MDR and IVDR—What's New?

    MDR and IVDR—What’s New? • Moving from “CE marking” to life-cycle approach • Integration of MEDDEV guidance on: - Clinical evaluations (clinical data) - Vigilance and post-market clinical follow-up - Requirements for economic operators (authorized representatives) • Rigorous Notified Body qualificat

  10. Slide 10: MDR Annexes—Changes for Sterile Packaging Shown in Red

    MDR Annexes—Changes for Sterile Packaging Shown in Red I. General safety and X. Conformity assessment based on type performance requirements examination II. Technical documentation XI. Conformity assessment based on product conformity verification III. Technical documentation on post-market surveill

  11. Slide 11: MDR Annexes

    MDR Annexes • Annex I MDD Essential Requirements (ERs) become General safety and performance requirements (SPRs) under the MDR • Annex II Technical documentation must include “validation reports, with respect to packaging, sterilization and maintenance of sterility” • Annex VII Requirements to be me

  12. Slide 12: The MDR General Safety and Performance Requirements

    The MDR General Safety and Performance Requirements What changes for sterile packaging?

  13. Slide 13: Key MDD Essential Requirements for Sterile Medical Packaging

    Key MDD Essential Requirements for Sterile Medical Packaging— EN ISO 11607 In summary: 8.1 …eliminate, or reduce as far as possible, the risk of infection to the patient Design must allow for easy handling and, where necessary, minimize contamination of the device by the patient or vice versa during

  14. Slide 14: Key MDR Safety and Performance Requirements for Sterile Medical Packaging

    Key MDR Safety and Performance Requirements for Sterile Medical Packaging—EN ISO 11607 In summary: 11.1 …eliminate, or reduce as far as possible, the risk of infection to the patient Design shall allow for easy and safe handling and… NEW minimize microbial contamination 11.4 …remain sterile, under t

  15. Slide 15: The New MDR vs. the MDD—In Relation to Sterile Packaging

    The New MDR vs. the MDD—In Relation to Sterile Packaging Annex I General safety and performance requirements Chapter III Requirements regarding the information supplied with the device 23 Label and instructions for use 23.3 Information on the “sterile packaging” (packaging that maintains the sterile

  16. Slide 16: Aseptic Presentation—Example of a Double Entry Sterile Barrier System

    Aseptic Presentation—Example of a Double Entry Sterile Barrier System Where is the Sterile Barrier System (SBS)? One or two validated SBS? Outer Barrier Inner Barrier Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™, For Greater Good™, Tyvek® and Tyvek® 2FS™ are trademark

  17. Slide 17: New Labeling Must Be Developed for the MDR

    New Labeling Must Be Developed for the MDR One of the new key requirements: …an indication permitting the sterile packaging to be recognized as such • Essential for double or triple entry packaging systems to optimize aseptic presentation Symbol proposal by the Sterile Barrier Association indicates

  18. Slide 18: Symbol Proposal by the Sterile Barrier Association

    Symbol Proposal by the Sterile Barrier Association • This proposed symbol: - Provides healthcare professionals with essential information about how to aseptically present the device and - Would allow compliance with the MDR—discussion ongoing Protective Validated Validated Validated Validated Protec

  19. Slide 19: Summary of Impact of New EU MDR/IVDR on Sterile Packaging

    Summary of Impact of New EU MDR/IVDR on Sterile Packaging • Validation of packaging, clear requirement, same level as sterilization—all must be included in technical documentation • Adding concepts of: - “sterile up to the point of use” - “prevention of microbial contamination” - “easy and safe hand

  20. Slide 20: EN ISO/DIS 11607:2017 Revision (Draft)—Key Focus Areas

    EN ISO/DIS 11607:2017 Revision (Draft)—Key Focus Areas • Alignment of definitions with other standards and ISO/DIS 11139 • Editorial changes for clarity and better flow of the document • Evaluation to assess aseptic presentation (usability evaluation) • Visual inspection of SBS before aseptic presen

  21. Slide 21: EN ISO/DIS 11607:2017 Revision—DIS Ballot

    EN ISO/DIS 11607:2017 Revision (Draft)—Key Focus Areas • Alignment of definitions with other standards and ISO/DIS 11139 • Editorial changes for clarity and better flow of the document • Evaluation to assess aseptic presentation (usability evaluation) • Visual inspection of SBS before aseptic presen

  22. Slide 22: Conclusion

    Conclusion • Many regulatory changes are coming in the near future • MDMs will need to: - Update their technical files - Recognize changes may have an impact on existing validations and packaging designs - Adapt labeling Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™, F

  23. Slide 23: Tools to Help You with Packaging Design and Regulatory Submissions

    Tools to Help You with Packaging Design and Regulatory Submissions

  24. Slide 24: We Are Applying Key Learnings from MPTP

    We Are Applying Key Learnings from MPTP • Collaboration with medical device manufacturers (MDMs) during the Tyvek® Medical Packaging Transition Project (MPTP) gave us: - A better understanding of the kind of data you need and - Insights of how best to present that data • New documents and online too

  25. Slide 25: A Selection of Major Tools from DuPont Tyvek

    A Selection of Major Tools from DuPont™ Tyvek® • Technical Reference Guides NEW - For Transition Tyvek® 1073B, Transition Tyvek® 1059B and Tyvek® 2FS™ - For Legacy Tyvek® 1073B, Legacy Tyvek® 1059B and Tyvek® 2FS™ (Updated June 2017) • Compliance Documents—Materials Portion of ISO 11607-1 Standard -

  26. Slide 26: New Technical Reference Guide—Available Soon in Two Versions

    New Technical Reference Guide—Available Soon in Two Versions Metric Units English Units Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™, For Greater Good™, Tyvek® and Tyvek® 2FS™ are trademarks or registered 26 trademarks of E.I. du Pont de Nemours and Company or its aff

  27. Slide 27: Technical Reference Guide—New Content, New Look

    Technical Reference Guide—New Content, New Look • Contains newest data and information for: - Transition Tyvek® 1073B - Transition Tyvek® 1059B - Tyvek® 2FS™ • Includes extensive application guidance and troubleshooting guidelines • Features reorganized chapters to help simplify data research • Is i

  28. Slide 28: Color-Coded Sections of the New Technical Reference Guide

    Color-Coded Sections of the New Technical Reference Guide General 1. Why is DuPont™ Tyvek® the preferred choice for sterile barrier systems? Material data I 2. DuPont™ Tyvek® — Properties Material data II 3. Biocompatibility, food contact, pharmacopeia and bioburden Sterilization compatibility 4. St

  29. Slide 29: Comparison of Properties—Tyvek vs. Medical-Grade Papers

    Comparison of Properties—Tyvek® vs. Medical-Grade Papers This is one of many figures showing comparison of properties Figure 7. DuPont™ Tyvek® vs. medical-grade papers: a comparison of properties—microbial barrier (ASTM F2638), Mullen burst (ISO 2758), Elmendorf tear (ASTM D1424 and EN 21974), elong

  30. Slide 30: New Particle Generation Data—Gelbo Flex Testing Method

    New Particle Generation Data—Gelbo Flex Testing Method Figure 14. Particles generated by Transition Tyvek® 1073B, Transition Tyvek® 1059B and two commonly used medical-grade papers (Gelbo Flex testing method, ISO 9073-10). Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™,

  31. Slide 31: Gelbo Flex Test Method ISO 9073-10

    Gelbo Flex Test Method ISO 9073-10 • Principle: tube made from test material twisted and compressed • Test chamber with particle counter • Results corrected based on count of empty chamber • “Dynamic” with movement or “Static” without movement • Well-established test method for cleanroom fabrics • C

  32. Slide 32: Why We Chose Gelbo Flex Testing for Particulate Measurements

    Why We Chose Gelbo Flex Testing for Particulate Measurements • Particulate testing is increasingly important as pharmaceutical and medical regulations and standards become more stringent • There are many types of methods, ranging from dry to wet, such as: - Visual inspection - Wet solvent extraction

  33. Slide 33: DuPont Tyvek—Properties Shown in Tables, Figures or Links

    DuPont™ Tyvek®—Properties Shown in Tables, Figures or Links • Specification properties • Dimensional stability study results • Miscellaneous properties • Coefficient of Friction (COF) study results • Differential Scanning Calorimetry (DSC) curves • Chemical resistance information • Infrared Spectrum

  34. Slide 34: Biological Evaluation Results

    Biological Evaluation Results Table II. Biocompatibility, food contact, pharmacopeia and bioburden testing results for Transition Tyvek® 1073B and Transition Tyvek® 1059B Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™, For Greater Good™, Tyvek® and Tyvek® 2FS™ are trade

  35. Slide 35: Sterilization Compatibility of Tyvek—Details and Data

    Sterilization Compatibility of Tyvek®—Details and Data • Ethylene oxide (EO) • Gamma radiation • Electron-beam radiation • Steam sterilization • Low-temperature oxidative sterilization Figure 20. Results of shrinkage tests and Gurley Hill porosity measurements conducted on Transition Tyvek® 1073B an

  36. Slide 36: Effects of Sterilization on DuPont Tyvek Properties

    Effects of Sterilization on DuPont™ Tyvek® Properties • Tensile strength (MD and CD) • Microbial barrier • Elongation (MD and CD) • Material color (L,a,b) • Puncture strength Figure 21. Effects of sterilization on material tensile strength (MD) for Transition Tyvek® 1073B, Transition Tyvek® 1059B an

  37. Slide 37: Performance of DuPont Tyvek After Aging

    Performance of DuPont™ Tyvek® After Aging • 5-year shelf-life • 1-, 3-, 5-, 7- and 10-year accelerated aging after different • 5-year real-time aging sterilization methods after EO sterilization • 1-year real-time aging after • 1- and 7-year real-time aging after different sterilization methods gamm

  38. Slide 38: Package System Performance Testing

    Package System Performance Testing • Mechanical properties • Transport simulation and subsequent testing • Storage requirements • Packaging exposed to liquid • This section includes links to extensive package performance studies, including several White Papers Copyright © 2017 DuPont. All rights res

  39. Slide 39: Extensive Application Guidance

    Extensive Application Guidance • Guidelines for printing • Labeling • Heat sealing guidelines • The unique structure of Tyvek® • Determining the rough vs. smooth side of Tyvek® • Package quality evaluation Figure 44. Microscopic view of the smooth side of DuPont™ Tyvek® (25x magnification). • Slitti

  40. Slide 40: Guidelines for Printing

    Guidelines for Printing • Flexographic printing • Lithographic printing • Variable information printing - Thermal transfer - Ink jet - Laser (electrostatic) • Barcode readability test results Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™, For Greater Good™, Tyvek® and

  41. Slide 41: Barcode Readability Test Results

    Barcode Readability Test Results Figure 41. Barcode readability results for Transition Tyvek® 1073B. Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™, For Greater Good™, Tyvek® and Tyvek® 2FS™ are trademarks or registered 41 trademarks of E.I. du Pont de Nemours and Compa

  42. Slide 42: Processing/Troubleshooting Guidelines

    Processing/Troubleshooting Guidelines • Avoiding fold problems • Over sealing or no seal transfer • Fiber tear • Controlling static charges during converting operations Figure 46. Pictorial representation of DuPont™ Figure 47. Pictorial representation of DuPont™ Tyvek® during package opening. Tyvek®

  43. Slide 43: New Technical Reference Guide—Available Soon

    New Technical Reference Guide—Available Soon • Get the data you need to help speed up your compliance process • Find valuable design and application guidance, as well as troubleshooting guidelines • Choose metric unit or English unit version • Coming soon to Medical Packaging Reference Library / Tec

  44. Slide 44: We Provide Regulatory and Packaging Science Support

    We Provide Regulatory and Packaging Science Support • DuPont Regulatory Affairs Experts are available globally to assist you with the support you need to: - Meet worldwide regulations and packaging standards - Accelerate your product regulatory submissions and certifications • DuPont Packaging Engin

  45. Slide 45: We're Here to Help

    We’re Here to Help • Attend a DuPont™ Tyvek® Seminar • Global webcasts—available on-demand near you: for up to a year via UBM, slide decks are available in the Medical Packaging - Costa Rica—January 2018 Knowledge Center - New Jersey—Spring 2018 • Tyvek® Rx eNewsletter - Germany—Spring 2018 • medica

  46. Slide 46: Questions?

    Questions?

  47. Slide 47: Thank you

    Thank you Today’s webcast will be archived for one year for on-demand viewing. For any additional questions, please contact us: • Daphne Allen, Editor, Pharmaceutical & Medical Packaging News at [email protected] • Or a member of the DuPont team at medicalpackaging.dupont.com Copyright © 2017 DuP

  48. Slide 48: Disclaimer

    Disclaimer This information corresponds to our current knowledge on the subject and may be subject to revision as new knowledge becomes available. It is your responsibility to investigate other sources of information on this issue that more appropriately addresses your product and its intended use.

  49. Slide 49: Copyright notice

    Copyright © 2017 DuPont. All rights reserved. The DuPont Oval Logo, DuPont™, For Greater Good™, Tyvek® and Tyvek® 2FS ™ are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. This presentation cannot be used without the express written consent of DuPont.

  50. Slide 50: Appendix

    Tyvek. Appendix

  51. Slide 51: The New MDR vs. the MDD—In Relation to Sterile Packaging

    The New MDR vs. the MDD—In Relation to Sterile Packaging Annex 1 – GENERAL SAFETY AND PERFORMANCE REQUIREMENTS - Chapter II Requirements regarding design and manufacture Medical Device Regulation Medical Device Directive Comments 11. Infection and microbial contamination 8. Infection and microbial A

  52. Slide 52: The new MDR versus the MDD in relation to packaging

    The new MDR versus the MDD in relation to packaging Annex 1 – GENERAL SAFETY AND PERFORMANCE REQUIREMENTS - Chapter II Requirements regarding design and manufacture Medical Device Regulation Medical Device Directive Comments 11.4. Devices delivered in a sterile state 8.3. Devices delivered in a ster

  53. Slide 53: The new MDR versus the MDD in relation to packaging

    The new MDR versus the MDD in relation to packaging Annex 1 – GENERAL SAFETY AND PERFORMANCE REQUIREMENTS - Chapter III Requirements regarding the information supplied with the device Medical Device Regulation MDD Comments 23.3. Information on the packaging which maintains the sterile (b) à 13.3 (c)

  54. Slide 54: The new MDR versus the MDD in relation to packaging

    The new MDR versus the MDD in relation to packaging Annex 1 – GENERAL SAFETY AND PERFORMANCE REQUIREMENTS - Chapter II Requirements regarding design and manufacture Medical Device Regulation Medical Device Directive Comments 11.5. Devices labelled as sterile shall be 8.4. Devices delivered in a ster

  55. Slide 55: The new MDR versus the MDD in relation to packaging

    The new MDR versus the MDD in relation to packaging Annex 1 – GENERAL SAFETY AND PERFORMANCE REQUIREMENTS - Chapter I General requirements Medical Device Regulation Medical Device Directive Comments 7. Devices shall be designed, 5. The devices must be “shall” statement manufactured and packaged in d

  56. Slide 56: The new MDR versus the MDD in relation to packaging

    The new MDR versus the MDD in relation to packaging Annex 1 – Essential Requirements Medical Device Regulation Medical Device Directive Comments 23.4. Information in the instructions for use 13.6. Where appropriate, the instructions Adding case of (l) If the device is supplied sterile, instructions

  57. Slide 57: The new MDR versus the MDD in relation to packaging

    The new MDR versus the MDD in relation to packaging Annex 1 – GENERAL SAFETY AND PERFORMANCE REQUIREMENTS - Chapter II Requirements regarding design and manufacture Medical Device Regulation Medical Device Directive Comments 11.8. The labelling of the device shall 8.7. The packaging and/or label of

DuPont — Technical Presentation (October 2017) on 6ix